Nicola Mordini

7PUBLICATIONS
61CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunologyRespiratory diseasesHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 02, 2026
Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.

|Jun 24, 2026
A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40-65 in first complete remission.

|Dec 02, 2025
Unrelated donor transplantation for relapsed refractory aplastic anemia, with quadruple GvHD prophylaxis.

Sabrina Giammarco, Andrea Bacigalupo, Nicola Mordini

|Jul 07, 2025
Perception of 'patient safety culture' among healthcare professionals in the field of haematopoietic stem cell transplantation and CAR-T therapy: a multicentre cross-sectional observational study by Italian Transplant Group for Bone Marrow Transplantation, Haematopoietic Stem Cells and Cell Therapy (GITMO).

Marco Cioce, Giuseppe Vetrugno, Angela Iula

|Feb 10, 2025
Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trial.

Anna Maria Raiola, Benedetto Bruno, Antonio Maria Risitano

|Jul 14, 2023
Nonrestrictive diet does not increase infections during post-HSCT neutropenia: data from a multicenter randomized trial.

Federico Stella, Vincenzo Marasco, Giorgia Virginia Levati

Pageof 2

Frequent Collaborators

3 joint publications

Massimo Martino

2 joint publications

Maria Teresa Lupo-Stanghellini

2 joint publications

Francesca Bonifazi

2 joint publications

Marco Cioce